Lifestyle Hydration Drip
A dual-solubility antioxidant, with an honest account of the research
Alpha lipoic acid is one of the more genuinely interesting molecules on our menu — an antioxidant that works in both water and fat compartments and regenerates other antioxidants. It also has a real clinical trial record, which is mixed, and we would rather walk you through it than skip past it.
Featured ingredients
Available at 200mg ($199), 400mg ($299) and 600mg ($399).
At a glance
A plain description of what is in the bag and what happens while you are here.
Unusual among antioxidants, which is why it reaches places others do not.
Its reduced form, dihydrolipoic acid, recycles vitamins C and E and supports glutathione synthesis.
ALA is an essential cofactor for the dehydrogenase complexes that feed the citric acid cycle.
Start at 200mg and step up with clinical guidance.
The science
We would rather tell you where the evidence is strong, where it is thin, and where it simply does not exist yet.
A naturally occurring dithiol compound and an essential cofactor for mitochondrial dehydrogenase complexes including pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase.
Both ALA and dihydrolipoic acid scavenge reactive oxygen species, and DHLA regenerates other antioxidants including vitamins C and E while supporting glutathione synthesis.
Nerve comfort in diabetes is where the trials live, and the results are mixed. Short-term IV studies — ALADIN at 600mg or 1200mg daily for three weeks, and the SYDNEY program — reported reductions in symptom scores versus placebo. However, the long-term oral NATHAN 1 trial at 600mg over four years did not meet its primary composite endpoint, and a 2024 systematic review of three randomised trials in 816 participants concluded ALA probably has little or no effect on neuropathy symptoms at 6 and 24 months, at moderate certainty. Short-term studies were more favourable than long-term ones.
ALA has no FDA-approved indication. It is not a treatment for cancer, and it is not an established treatment for Alzheimer's disease or cognitive decline — the human data there are limited, small and largely uncontrolled. Evidence in liver disease is preclinical. We offer this as antioxidant support, described accurately.
Who commonly considers this: Adults interested in antioxidant support, sometimes including those with diabetes-related nerve discomfort who are already under a physician's care and curious about an adjunct.
This button goes straight to the live calendar for this treatment — real availability, updated as appointments are taken. Prefer to talk it through first? Call us.
Visit us
The DRIPBaR Frisco
3311 Preston Rd, Ste 9, Frisco, Texas 75034
Tel: 469-466-1134
Zen Health PLLC · Physician: Dr. Aminidhan D. Thakkar, MD
